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This project was done for internal quality 
improvement, thus was exempt from IRB. All LVHN 
primary care patients between the ages of 2 and 
18 years old with a BMI greater than or equal to 
the 85th percentile are eligible, with no exclusions 
placed on gender or ethnicity. The LVHN Pediatric 
Obesity Prevention and Management Pathway was 
used as a guideline for inclusion of comorbidities 
to be incorporated in the screening template. 
The comorbidity screening template consists 
of 25 common comorbidities seen in pediatric 
patients with obesity.3 Information was gathered 
by conducting literature searches of specific 
comorbidities within the systems of cardiovascular, 
gastrointestinal, nutrition, endocrine, respiratory, 
neurologic, orthopaedic, genetic, and mental health 
(Appendix, Table 1). Comorbidities were included 
in the template based on recommendations from 
LVHN’s Pediatric department, as well as prominence 
in the literature. Patients are deemed to have a 
comorbid condition if the condition was diagnosed 
either contemporaneously with or following 
the initial documentation of the patient being 
overweight or obese. 
The prevalence of obesity in the United States has 
been steadily increasing and pediatric obesity has 
become a common problem seen in the primary 
care setting. A study that looked at obesity trends 
in US children and adolescents from 1999-
2010 found that nationally in 2009-2010 16.9% 
of children were obese and 31.8% were either 
overweight or obese, with 12.3% of children falling 
above the 97th percentile of BMI for age.1 Clinical 
care pathways can improve the quality of clinical 
decision making by offering specific and detailed 
guidelines for clinicians, provide authoritative 
recommendations that reassure practitioners 
about the appropriateness of their treatment plans, 
and improve the consistency and effectiveness of 
medical care thereby optimizing patient outcomes.2 
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Methods
The CDC estimates that presently one-third of children and adolescents are overweight or 
obese in the United States. Chart reviews conducted in 2014 of two LVHN pediatric practices 
of over 100 patient charts from each revealed the prevalence of pediatric obesity in LVHN 
practices ranged from 30-36% of patients. A comorbidity screening sheet was constructed 
and designed to be used by physicians and other healthcare professionals to help manage 
pediatric patients whose BMIs classify them as overweight or obese. 25 comorbidities 
were selected for inclusion in the screening template (Appendix, Figure 1). This tool aims 




Standardizing patient care and the use of clinical care pathways has been shown to improve 
patient outcomes and may improve efficiency and optimize value for the healthcare system 
by reducing unnecessary testing, procedures, and prescriptions.2 The comorbidity screening 
sheet was developed to be implemented into the EPIC electronic medical record and applied 
to the care of overweight and obese pediatric patients at LVHN. The goal of this standardized 
process is to properly diagnose and treat the multiple complications that are associated with 
the growing epidemic of pediatric obesity. The template will do this by providing specific 
recommendations about frequency of screenings, how to address abnormal laboratory 
results, and when and whom to make referrals to. Further study includes assessing patient 
outcomes and the cost effectiveness of this process. The process of developing this 
screening template may be applied to other areas of both pediatric and adult care to optimize 
the use of electronic medical record at LVHN.
Conclusions and Future Implications
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We sought to standardize the way Lehigh Valley 
Health Network’s primary care physicians manage 
and assess the comorbidities associated with 
pediatric obesity.
Problem Statement
Figure 1: LVHN Comorbidity Screening Template
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Respiratory Asthma;Obstructive Sleep Apnea














LVHN Comorbidity Screening Template 
Cardiovascular 
• Hypertension 
– Patient’s blood pressure within normal limits for age group? 
• Yes 
– Repeat yearly 
• No, consider 
– Cardiology referral 
– Dietitian referral 
– Labs/Studies 
» Urinalysis 
» Fasting lipid panel 
» Fasting glucose 
» TSH, free T4 
» Renal ultrasound with doppler of renal vascular 
» EKG 
• Hyperlipidemia 
– Risk factors 
• Has anyone had a heart attack or bypass surgery under the age of 65? 
– If so, at what age? (Note, early cardiac disease if < 55 yrs in men and <65 yrs in 
women) 
• Has anyone in the family died suddenly? 
• Parental history of high cholesterol? 
– If yes to any of the above, consider earlier screening between ages 2-8 with two 
average fasting lipid profiles 
– Labs done within the past 2 years? 
• Yes 
– Normal 
– Abnormal * (* indicates clinician must respond by placing an order or denoting why 
an order was not placed) 





» Fasting lipid profile 
» Non-fasting lipid profile 
– Deferred* 
Gastrointestinal 
• Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic 
Steatohepatitis(NASH) 
– AST and ALT 




» Repeat AST/ALT 
» RUQ ultrasound 





– Gallbladder disease 
• Potential associated symptoms 
– Recurrent abdominal pain 
– Vomiting 
• If positive, consider 
– RUQ ultrasound 
– GERD 
• Potential associated symptoms 
– Vomiting 
– Acid Reflux 
– Epigastric Pain 
– Chronic cough 
• If positive, consider 
– Diet changes 
– Antacid 
– PPI Therapy 
– UGI 
Nutrition 
– Iron Deficiency 
• Risk factors/symptoms of anemia? 
– Fatigue 
– Pallor 
– Diet history of excessive cow milk consumption/low iron diet 
• If yes, consider 
– CBC 
– Iron studies 
• Vitamin D Deficiency 
– Review diet history 
– 25 OH Vitamin D level 
» Normal 
» Abnormal* 
» Repeat Vitamin D 
» Order Vitamin D 
• Cholecalciferol 
• 400u/ml liquid 
• 1,000u chew 
• 2,000u capsule 
• 5,000u capsule 
• Ergocalciferol 
50,000u capsule  
Endocrine 
– Diabetes 
• Risk factors/Symptoms 
– Family history 
– Polyuria 
– Polydipsia 
– Nocturia/new onset enuresis 
– Acanthosis Nigricans 
• If any of the above are positive, consider 
– HbA1c 
– Fasting insulin/glucose 





• Fasting insulin/glucose 
• Oral glucose tolerance test 




• Fasting insulin/glucose 
• Oral glucose tolerance test 
» Deferred*  
– PCOS 
• Verbal screen 
– History of irregular menses > 2 years post menarche? (irregular for 6 
months or no menses for 3 months) 
– Signs of hyperandrogenism? (e.g. hirsutism, male pattern hair, balding or 
severe acne) 
– Signs of insulin resistance? (e.g. presence of acanthosis) 
– Need 3 positive answers to have a positive screen 
– If positive screen, consider referral to 
» Adolescent Medicine 
» Endocrine 
– Hypothyroid 
• Risk factors/symptoms 
– Family history 
– Slow linear growth 
– Excessive fatigue 
– Goiter 
• If any of the above are positive 
– TSH 
– Free T4 
• TSH >5? 
– If yes, consider 
» TSH 
» Free T4 
» Anti-thyroid peroxidase Ab 
» Anti-thyroglobulin Ab 
» Endocrine referral 
– Cushing’s disease 
• Risk factors/symptoms 
– Family history 
– Violaceous striae 
– Muscle weakness 
– Buffalo hump 
– Moon facies 
– Slow linear growth 
• If any of the above are positive, consider 




– Cough/Shortness of breath with exercise or during sleep 
– Wheezing 
• If yes, consider 
– Spirometry 
– CXR 
– Trial of bronchodilator 
– Asthma clinic/pulmonary referral 
– Sleep Apnea 
• Enlarged tonsils 
• Verbal screen 
– Snoring 3 or more nights a week? 
– Difficulty breathing during sleep (i.e. work hard to breathe, gasp 
for air, have retractions)? 
– School problems, ADHD or daytime sleepiness (fall asleep at 
school)? 
– If 2 out of  3 positive, screen is positive 
» Sleep study 
» Sleep center referral 
Neurologic 
– Pseudotumor Cerebri Syndrome 
• Verbal screen 
– Unexplained near-daily headaches (which may be worse in the 
supine position or upon awakening)? 
– Blurry or double vision? 
– Pulsatile tinnitus (heartbeat or whooshing sounds in the ears)? 
– If any one positive, screen is positive 
» Urgent Ophthalmology referral 
Orthopedic Conditions 
– SCFE, Blount’s Disease 
• Screening questions for SCFE 
– Pain in hip, knee or leg 
– Limp 
– Decreased hip range of motion 
– Unequal leg lengths 
• If patient has associated symptoms, consider imaging 
– SCFE with stable hips – Bilateral AP & Frog Leg Hip Xrays 
– SCFE with unstable hips – Bilateral PA & Lateral Hip Xrays 
• Screening question for Blount’s Disease 
– Leg bowing 
• If patient has associated symptoms, consider imaging 
– Bilateral Standing AP & Lateral LE Xray from hip to floor 
– Spondylolysis, Spondylolisthesis, Disc Disease 
• Screening questions 
– Pain in back, buttocks or leg 
– Sciatica 
– LE weakness 
– LE numbness 
– Decreased ROM of back 
• If positive, consider 
– Positive neurological exam – MRI of the spine 
– Negative neurological exam – Lumbar Spine Xrays AP, Lateral 
and Oblique 
Genetic Disorders 
– Prader-Willi, Bardet-Biedl, Down Syndrome, Fragile X 
• Potential physical exam findings 
– Short stature 
– Delayed development 
– Syndromal apperance 
– Undescended testes 
– Micropenis 
– Small hands and feet 
– Polydactyly 
• If positive, consider 
– Chromosomal testing 
– Genetics referral 
Mental Health 
– Pediatric Symptom Checklist 
• Depression 
• Anxiety 
• Eating disorder 
– Binging/purging, stealing/hoarding food 
• If positive, 
– Behavioral Health referral 
– Bullying/Abuse/Violence Screening Questionnaire for Children 
• If positive, consider referral to 
– Child Advocacy Center 
